Fidessa's Steve Grob responds to CME chairman emeritus Leo Melamed's defence of HFT.
Interesting to read the venerable Leo Melamed’s
open letter in the FT this week on HFT and regulators. The
CME’s chairman emeritus certainly makes a good
point when he says that trying to stifle innovation is both
wrong and inevitably doomed to failure, but I am not sure
he’s completely right in a couple of areas.
First, whilst it’s true that algorithmic or HFT
players have indeed had the effect of narrowing spreads, this
is not always the best thing...
This article is available to subscribers and registered users
Please log in to continue reading.
Not yet registered? Take a free trial.
If you have already taken a free trial you
have ongoing access to the analysis section of FOW.com including this story.
Log in using your details below to read.
Already have an account? |